Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01451476 · ClinicalTrials.gov registry record
Human Skin Aging: Clinical Parameters and Gene Expression Profiling
A clinical trial of Ageing, sponsored by Stanford University.
- Completed
- Registry status
- 122
- Enrollment target
- 1
- Study location
NCT01451476: Completed study of Ageing, sponsored by Stanford University.
NCT01451476 is a study of Ageing that has completed, run by Stanford University. The registered enrollment target is 122 participants. The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01451476, a study of Ageing, has completed, sponsored by Stanford University.
- COMPLETED
- Registry status
- 122 participants
- Enrollment target
- 1
- Study location
Study Summary
Skin aging is a complex process involving genetic and environmental factors. The investigators hope to learn more about how human genes and their function can contribute to skin aging and human health.
Conditions Studied
Study Locations (1)
California
- Stanford Dermatology - Redwood City
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 122 participants |
| Start Date | 2010-05 |
| Est. Completion | 2015-12 |
What the finished NCT01451476 record still lists
NCT01451476 is an observational study that tracks outcomes without assigning an intervention. The registered 122 participants enrollment target is mid-sized for trials with a published cap.
The record links to 1 condition, with Ageing appearing as the primary indexed condition, and to 0 interventions.
NCT01451476 reports a single indexed study location in California.
Frequently Asked Questions
What is clinical trial NCT01451476 about?
NCT01451476 is a clinical study titled "Human Skin Aging: Clinical Parameters and Gene Expression Profiling". Skin aging is a complex process involving genetic and environmental factors. The investigators hope to learn more about how human genes and their function can contribute to skin aging and human health.
What is the current status of trial NCT01451476?
This trial is currently completed. The enrollment target is 122 participants. The study started on 2010-05. Estimated completion is 2015-12.
What conditions does trial NCT01451476 study?
This clinical trial studies the following conditions: Ageing.
Who is sponsoring clinical trial NCT01451476?
This trial is sponsored by Stanford University, which has 1,744 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT01451476 being conducted?
This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03363373 · 122 participants · Phase 2
Naxitamab for High-Risk Neuroblastoma Patients With Primary Refractory Disease or Incomplete Response to Salvage Treatment in Bone and/or Bone Marrow
- NCT03463954 · 122 participants · NA
Confirmatory Clinical Evaluation of Novilase® Laser Therapy for Focal Destruction of Malignant Breast Tumors
- NCT04503265 · 122 participants · Phase 1
A Trial of AMXI-5001 for Treatment in Patients With Advanced Malignancies
- NCT04700527 · 122 participants · Phase 1
The Effects of SCFA Supplementation in Subjects Receiving Abdominopelvic RT: A Randomized Controlled Study
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia